Merck Seeks To Quash Ranbaxy's Subpoenas
In a third-party motion filed Monday, Merck asked the U.S. District Court for the District of New Jersey to quash a recent subpoena for information that Ranbaxy claimed it needed in its ongoing patent litigation with Pfizer Inc. in that court.
Merck said that it had been bombarded...
To view the full article, register now.
Try Law360 FREE for seven days
Already a subscriber? Click here to login